or Try an Advanced Search...

    Technical Analysis for AMLX - Amylyx Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 5.12 -2.20% -0.12
    AMLX closed up 0.19 percent on Wednesday, November 20, 2024, on 58 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical AMLX trend table...
    Date Alert Name Type % Chg
    Golden Cross Bullish -2.20%
    NR7 Range Contraction -2.20%
    Inside Day Range Contraction -2.20%
    Wide Bands Range Expansion -2.20%
    Oversold Stochastic Weakness -2.20%
    Wide Bands Range Expansion -2.01%
    Oversold Stochastic Weakness -2.01%
    20 DMA Resistance Bearish -3.49%
    New Uptrend Bullish -3.49%
    Pocket Pivot Bullish Swing Setup -3.49%
    Older End-of-Day Signals for AMLX ...

       Recent Intraday Alerts

    Alert Time
    1.5x Volume Pace 39 minutes ago
    60 Minute Opening Range Breakdown about 1 hour ago
    Down 3% about 2 hours ago
    Fell Below Previous Day's Low about 2 hours ago
    Down 2 % about 2 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AMLX Chart by TradingView
    Basic chart:

    Profile

    Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Neurodegenerative Disease Apoptosis

    Is AMLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Amylyx Pharmaceuticals upgraded to Outperform at Baird, shares rise
    Nov 9 Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2024 Earnings Call Transcript
    Nov 9 Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)
    Nov 8 Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
    Nov 8 Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call
    Nov 7 Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
    Nov 4 Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
    Oct 26 Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc
    Oct 23 Amylyx upgraded to buy by BofA on hypoglycemia drug potential
    Oct 21 October 2024's US Penny Stocks Poised For Growth
    See more AMLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.9488
    52 Week Low 1.575
    Average Volume 1,598,688
    200-Day Moving Average 4.24
    50-Day Moving Average 4.28
    20-Day Moving Average 5.62
    10-Day Moving Average 5.77
    Average True Range 0.58
    RSI (14) 50.98
    ADX 44.52
    +DI 26.92
    -DI 19.81
    Chandelier Exit (Long, 3 ATRs) 5.52
    Chandelier Exit (Short, 3 ATRs) 6.20
    Upper Bollinger Bands 6.84
    Lower Bollinger Band 4.40
    Percent B (%b) 0.34
    BandWidth 43.53
    MACD Line 0.29
    MACD Signal Line 0.49
    MACD Histogram -0.2006
    Fundamentals Value
    Market Cap 353.12 Million
    Num Shares 67.5 Million
    EPS 0.01
    Price-to-Earnings (P/E) Ratio 523.00
    Price-to-Sales 3.73
    Price-to-Book 2.49
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.68
    Resistance 3 (R3) 5.68 5.54 5.61
    Resistance 2 (R2) 5.54 5.42 5.54 5.58
    Resistance 1 (R1) 5.38 5.35 5.46 5.38 5.55
    Pivot Point 5.24 5.24 5.28 5.24 5.24
    Support 1 (S1) 5.08 5.12 5.16 5.08 4.91
    Support 2 (S2) 4.94 5.05 4.94 4.88
    Support 3 (S3) 4.78 4.94 4.86
    Support 4 (S4) 4.78